|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received September 14, 2003
Revised October 3, 2003
Accepted after revision October 24, 2003
1 SUNY Buffalo
2 University at Buffalo, SUNY
* To whom correspondence should be addressed. E-mail: rr32{at}acsu.buffalo.edu.
C-type inactivation is present in many voltage-gated
potassium channels, and is probably related to "slow"
inactivation in calcium and sodium channels. The
mechanisms underlying C-type inactivation are unclear,
but it is sensitive to mutations on both the
extracellular and intracellular sides of the channel. We
used an N-terminal deleted channel with a valine to
alanine point mutation at the intracellular side of S6
(fKv1.4[V561A]
N). This construct alters recovery
from inactivation and inverts the relationship between C-
type inactivation and [K+]o. We used this inverted
relationship to examine C-type inactivation and coupling
mechanisms between N- and C-type inactivation. The
valine to alanine mutation reduces the channel's
affinity for both quinidine and the N-terminal domain.
However, binding of the N-terminal or quinidine restores
normal recovery from inactivation. This suggests that
coupling between N-and C-type inactivation is dominated
by allosteric mechanisms. The permeation mechanism,
driven by a reduction in permeant [K+]o following pore
block (which would retard C-type inactivation),
contributes minimally to coupling in these channels.
We propose that the cytoplasmic half of S6 forms
part of the N-terminal binding site, as previously
predicted from X-ray crystallography studies in the
distantly-related KcsA channel. Binding of the N-
terminal domain or a positively charged lipophilic
compound such as quinidine interacts with the
hydrophobic moieties on S6 in the bound state. This
binding can orient S6 into a conformation which
resembles the normal C-type inactivated state. This
is the likely mechanism by which drug or N-terminal
binding increases the rate of C-type inactivation via an
allosteric mechanism.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |